Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Molecular study of malignant gliomas treated with the EGFR inhibitor, elotinib (OSI-774): Tissue analysis from a North American Brain Tumor Consortium (NABTC) study

Molecular study of malignant gliomas treated with the EGFR inhibitor, elotinib (OSI-774): Tissue analysis from a North American Brain Tumor Consortium (NABTC) study. Clin Cancer Res. 2005; 11:7841-7850.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.